(Q36506702)

14 August 2017

title

Effects of botulinum toxin type A on upper limb function in children with cerebral palsy: a systematic review (English)

1 reference

14 August 2017

1 reference

botulinum toxin type A

1 reference

4

Gert Kwakkel

1 reference

14 August 2017

Alexander Reeuwijk

1

1 reference

14 August 2017

Petra E M van Schie

series ordinal

2

1 reference

14 August 2017

Jules G Becher

series ordinal

3

1 reference

14 August 2017

language of work or name

1 reference

1 May 2006

1 reference

14 August 2017

published in

Clinical Rehabilitation

1 reference

14 August 2017

volume

20

1 reference

14 August 2017

issue

5

1 reference

14 August 2017

page(s)

375-387

1 reference

Proposed definition and classification of cerebral palsy, April 2005.

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1191%2F0269215506CR956OA

Changing panorama of cerebral palsy in Sweden. VIII. Prevalence and origin in the birth year period 1991-94.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0269215506CR956OA

Management of upper limb dysfunction in children with cerebral palsy: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0269215506CR956OA

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0269215506CR956OA

Occupational therapy for children with cerebral palsy: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0269215506CR956OA

Exercise therapy for low back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0269215506CR956OA

Management of the upper limb with botulinum toxin type A in children with spastic type cerebral palsy and acquired brain injury: clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0269215506CR956OA

Botulinum toxin A in the management of upper limb spasticity in cerebral palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0269215506CR956OA

Changes in movement characteristics of the spastic upper extremity after botulinum toxin injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0269215506CR956OA

Motor control testing of upper limb function after botulinum toxin injection: a case study

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0269215506CR956OA

Functional outcomes of intramuscular botulinum toxin type A in the upper limbs of children with cerebral palsy: a phase II trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0269215506CR956OA

Open-label study of botulinum toxin for upper limb spasticity in cerebral palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0269215506CR956OA

Botulinum A chemodenervation: a new modality in cerebral palsied hands

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0269215506CR956OA

Reliability of the Melbourne assessment of unilateral upper limb function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0269215506CR956OA

Therapeutic uses of botulinum toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0269215506CR956OA

Method Guidelines for Systematic Reviews in the Cochrane Collaboration Back Review Group for Spinal Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0269215506CR956OA

10.1191/0269215506CR956OA

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference